Wuhan Huisheng Biotechnology has provided a joint liability guarantee for a 60 million yuan fixed asset loan to its wholly-owned subsidiary Xinjiang Huisheng Biotechnology. The company signed a guarantee contract with the Bank of China Yili Kazakh Autonomous Prefecture Branch. This guarantee falls within the 2026 annual guarantee quota and does not require further approval from the board of directors or shareholders' meeting. Xinjiang Huisheng was established in November 2025 with a registered capital of 300 million yuan and is currently in the construction phase, not yet fully operational. After this guarantee, the actual guarantee balance of the company and its controlled subsidiaries is 218.18 million yuan, accounting for 10.04% of the audited net assets in 2025. All guarantees are within the scope of consolidated financial statements, with no overdue guarantees or guarantees involved in litigation. The company has previously obtained approval to provide guarantees not exceeding 600 million yuan for its consolidated subsidiaries in 2026.
Wuhan Hvsen Biotechnology Co LtdCompany provides guarantee for subsidiary's loan, increasing contingent liability but within approved quota and consolidated scope.
